Results 111 to 120 of about 4,065 (123)

[Study on the correlation between sarcopenia, energy metabolism, and the severity of liver disease in patients with type 2 diabetes mellitus combined with metabolic associated fatty liver disease]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Zhang J, Li Y, Ye Q, Yan NN, Yu HY, Wang FM, Di FS.   +6 more
europepmc   +1 more source

[Chinese guidelines for clinical diagnosis, treatment, and management of cirrhosis (2025)]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Chinese Society of Hepatology, Chinese Medical Association.   +1 more
europepmc   +1 more source

[A stable mouse model of chronic liver fibrosis induced by vitamin A deficiency and intraperitoneal CCl₄ injection]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Yang T, Zhao L.
europepmc   +1 more source

[Recent Advances in the Interorgan Regulatory Roles of Adipose Tissue]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Li Z, Xu C, Xu R, Zhou C, Fan Y.
europepmc   +1 more source

[Role of serum Golgi protein 73 in the assessment of pathological prognosis and its inflammatory influencing factors for hepatitis B virus-related liver fibrosis]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Fan HN, Ma YQ, Sun X, Huang K, Xing F, Liu CH.   +5 more
europepmc   +1 more source

[Aloe-emodin inhibits scar tissue fibrosis through thrombospondin-1-PI3k-Akt pathway]. [PDF]

Hua Xi Kou Qiang Yi Xue Za Zhi
Geng H, Zhang X, Zhou S, Li N, Liu J, Yuan X, Ning C, Zhang X, Huang W.   +8 more
europepmc   +1 more source

[Progress in clinical research related to viral hepatitis in 2025]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Ding Y, Li Y, Dou XG.
europepmc   +1 more source

[The application of thrombopoietin receptor agonists in the treatment of non-muscle myosin heavy chain 9-related disease]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Gong Y, Chen WL, Hu YJ, Mei H, Wang YD.
europepmc   +1 more source

[Exploring the research on the molecular mechanisms of autoimmune liver diseases]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Liu YQ, Jiang XW, Li Y, Liu XL.
europepmc   +1 more source